Viz Pulmonary Embolism Solution

Viz PE with RV/LV ratio is the first FDA-cleared, fully-automated
solution that detects suspected PE and right heart strain. The
HIPAA-compliant communication tool streamlines the workflow across the
healthcare system, empowering healthcare providers to deliver faster and
optimal care for patients with PE.

Obsidio Conformable Embolic

Obsidio Conformable Embolic is a novel biomaterial for transcatheter
intravascular embolization to treat hypervascular tumors and
hemorrhaging. This shear-thinning hydrogel is directly injected to the
vessel and forms a solid cast to immediately halt blood flow without
relying on precipitation, polymerization, or the patient’s ability to
clot.

Alinity i TBI lab test

Abbott’s Alinity i TBI lab test is the first commercially available
laboratory blood test for concussions. This test objectively measures
two biomarkers in the blood that, in elevated numbers, tightly correlate
to brain injury. It also rules out the need for a CT scan and will
increase access to reliable TBI testing.

EarliPoint™️ Evaluation

EarliPoint Evaluation is a first-of-its-kind advancement – an
FDA-authorized tool to aid clinicians in diagnosing and assessing autism
for children ages 16 to 30 months of age. EarliPoint Evaluation enables
earlier identification and diagnosis of autism and removes many of the
barriers that delay diagnosis today.

Galen™ Breast HER2

Many breast cancer patients have low levels of HER2 expression and can
benefit from newly developed therapies, however accurately identifying
these patients is a challenge. Galen™ Breast HER2 augments the
pathologist’s diagnosis and supports treatment decisions with AI-powered
insights providing precise, rapid, reproducible biomarker scoring.

DNBSEQ-T20×2

“DNBSEQ-T20×2’s launch becomes an important force driving the
development and expansion of the global genetic industry, accelerates
the progress of the human genome understanding and medical applications,
and fundamentally reshapes the biotech industry ecology.”

Key Functional Cell Identity (KFCI)

KFCI is a new technology that identifies potent therapeutic cells,
creating a stem-cell bank for developing cell therapy products to treat
more than 40 medical conditions, including diabetes and myocardial
infarction. This platform accelerates cell therapy development and
production by filtering out ineffective samples, reducing costs by 90%.

NanoSwab – Bio-inspired Microstructure for Human Papillomavirus DNA Detection in Male

NAMI’s NanoSwab is a biomimetic sampler tailored for male genital cell
collection. Inspired by natural microstructure like setae, uniform
micropillars on NanoSwab harness friction to collect and trap adequate
cells in a single step for subsequent HPV DNA detection in men without
any discomfort; it fills a critical gap in male-centric HPV screening.

SurgicalAR®

Medivis leverages AR, AI and computer vision to bring accuracy and
precision to surgeries. Our SurgicalAR technology translates complex 2D
medical imaging such as MRIs and CTs into 3D holographic visualizations
to enhance surgical accuracy and patient outcomes, reducing operational
risks, and ultimately, elevating the standard of care globally.

SutureLoc™ Implant

SutureLoc is the first knotless, retensionable soft anchor designed
specifically for arthroscopic meniscal root repair. The all-suture soft
anchor is designed for retrograde insertion directly under the repair
subcortically, improving fixation strength and stiffness by eliminating
suture fixation devices in the anterior tibia.

Ready for Nomination Season?

Complete the form below to download the 2027 Nomination Guide.

A Founders Guide to Modern Innovation
The Future of the Grid – Panel Discussion 2024 Edison Awards
Edison Award-Winning Brain Technology Featured in U.S. News & World Report